HER2-:

Jia Cong1, HyonSu Jo2,3, Na Zou4

  • 1Department of Breast Surgery, Dalian Women and Children's Medical Group, Dalian, People's Republic of China.

概括

阳性HER2的阿坎托利性状细胞癌 (ASCC) 是罕见的. 新辅助疗法在患有HER2阳性乳腺ASCC的患者中显示出有效性,在1.5年后没有复发.